Erdafitinib Antagonizes ABCB1-Mediated Multidrug Resistance in Cancer Cells

od Feng, Weiguo, Zhang, Meng, Wu, Zhuo-Xun, Wang, Jing-Quan, Dong, Xing-Duo, Yang, Yuqi, Teng, Qiu-Xu, Chen, Xuan-Yu, Cui, Qingbin, Yang, Dong-Hua
Izdano u Front Oncol (2020)

NVP-CGM097, an HDM2 Inhibitor, Antagonizes ATP-Binding Cassette Subfamily B Member 1-Mediated Drug Resistance

od Zhang, Meng, Chen, Xuan-Yu, Dong, Xing-Duo, Wang, Jing-Quan, Feng, Weiguo, Teng, Qiu-Xu, Cui, Qingbin, Li, Jing, Li, Xiang-Qi, Chen, Zhe-Sheng
Izdano u Front Oncol (2020)

Bruton’s Tyrosine Kinase (BTK) Inhibitor RN486 Overcomes ABCB1-Mediated Multidrug Resistance in Cancer Cells

od Dong, Xing-Duo, Zhang, Meng, Ma, Xiubin, Wang, Jing-Quan, Lei, Zi-Ning, Teng, Qiu-Xu, Li, Yi-Dong, Lin, Lusheng, Feng, Weiguo, Chen, Zhe-Sheng
Izdano u Front Cell Dev Biol (2020)

Methyl-Cantharidimide (MCA) Has Anticancer Efficacy in ABCB1- and ABCG2-Overexpressing and Cisplatin Resistant Cancer Cells

od Li, Yi-Dong, Mao, Yong, Dong, Xing-Duo, Lei, Zi-Ning, Yang, Yuqi, Lin, Lizhu, Ashby, Charles R., Yang, Dong-Hua, Fan, Ying-Fang, Chen, Zhe-Sheng
Izdano u Front Oncol (2020)